---
category: news
title: "BioXcel Therapeutics Announces Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501"
excerpt: "BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology,"
publishedDateTime: 2020-05-14T11:13:00Z
webUrl: "https://markets.businessinsider.com/news/stocks/bioxcel-therapeutics-announces-completion-of-patient-enrollment-in-phase-3-serenity-trials-with-bxcl501-1029201411"
type: article
quality: 18
heat: 18
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

secured: "I34Pn/qELC1J5k2R3ch5mc/SEkY5GDn9mbE4WGXSc7IFm19M0+Qp/jNdDX/PL6OHpHgIcARsa9WAgQKHD3KiMU478PQozxnYp7RSm7cGrHZtYqnbKB2jKsI31JtFDY+hJU0psTGG8LFsK0Kbf8MUlRpZOcpdjGp5OJWln5R3XNN6OhaLkVwb+IlvHqxvHBol6G6otYetRxB5Htz0v1k3+Ur2yHnKukw4/1Z55DFHDZG4e07CUVVy5sjYdwHG0a6tPni3ILeovOeySjH+RPaRJj4jDXkez2+UZviKfcBF5gXv2K1UOxz51iy4i1jxWDVh;cn2juYZQ64EM2Pu4MTtD/g=="
---

